Voyageur Pharmaceuticals Stock Market Outlook
| VYYRF Stock | USD 0.11 0.02 15.38% |
Roughly 61% of Voyageur Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Voyageur Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Voyageur Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Voyageur Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Comfort Level 39
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Voyageur Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Voyageur Pharmaceuticals.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Voyageur Pharmaceuticals is 'Strong Sell'. Macroaxis provides Voyageur Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VYYRF positions.
Execute Voyageur Pharmaceuticals Advice
The Voyageur recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Voyageur Pharmaceuticals. Macroaxis does not own or have any residual interests in Voyageur Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Voyageur Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Fair | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Moderate | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Voyageur Pharmaceuticals has a Mean Deviation of 87.49, Standard Deviation of 361.09 and Variance of 130389.19We provide advice to complement the current expert consensus on Voyageur Pharmaceuticals. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Voyageur Pharmaceuticals is not overpriced, please validate all Voyageur Pharmaceuticals fundamentals, including its ebitda, as well as the relationship between the current ratio and beta . As Voyageur Pharmaceuticals appears to be a penny stock we also recommend to double-check its debt to equity numbers.
Voyageur Pharmaceuticals Trading Alerts and Improvement Suggestions
| Voyageur Pharmaceuticals is way too risky over 90 days horizon | |
| Voyageur Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Voyageur Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Voyageur Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Voyageur Pharmaceuticals has accumulated 25.52 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Voyageur Pharmaceuticals has a current ratio of 0.33, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Voyageur Pharmaceuticals has accumulated about 247.78 K in cash with (1.65 M) of positive cash flow from operations. | |
| Roughly 14.0% of Voyageur Pharmaceuticals outstanding shares are owned by insiders |
Voyageur Pharmaceuticals Returns Distribution Density
The distribution of Voyageur Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Voyageur Pharmaceuticals' future price movements. The chart of the probability distribution of Voyageur Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Voyageur Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Voyageur Pharmaceuticals returns is essential to provide solid investment analysis for Voyageur Pharmaceuticals.
| Mean Return | 43.25 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 55.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Voyageur Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Voyageur Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Voyageur Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Voyageur Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Voyageur pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 48.00 | |
β | Beta against Dow Jones | -79.47 | |
σ | Overall volatility | 125.91 | |
Ir | Information ratio | 0.12 |
Voyageur Pharmaceuticals Volatility Alert
Voyageur Pharmaceuticals is displaying above-average volatility over the selected time horizon. Voyageur Pharmaceuticals is a potential penny stock. Although Voyageur Pharmaceuticals may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Voyageur Pharmaceuticals. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Voyageur instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Voyageur Pharmaceuticals Fundamentals Vs Peers
Comparing Voyageur Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Voyageur Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Voyageur Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Voyageur Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Voyageur Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Voyageur Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Voyageur Pharmaceuticals to competition |
| Fundamentals | Voyageur Pharmaceuticals | Peer Average |
| Return On Equity | -0.77 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Current Valuation | 5.74 M | 16.62 B |
| Shares Outstanding | 132.7 M | 571.82 M |
| Shares Owned By Insiders | 14.29 % | 10.09 % |
| Price To Book | 4.11 X | 9.51 X |
| EBITDA | (2.05 M) | 3.9 B |
| Net Income | (2.05 M) | 570.98 M |
| Cash And Equivalents | 247.78 K | 2.7 B |
| Total Debt | 25.52 K | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 0.34 X | 2.16 X |
| Book Value Per Share | 0.02 X | 1.93 K |
| Cash Flow From Operations | (1.65 M) | 971.22 M |
| Earnings Per Share | (0.02) X | 3.12 X |
| Number Of Employees | 10 | 18.84 K |
| Beta | 0.9 | -0.15 |
| Market Capitalization | 9.93 M | 19.03 B |
| Total Asset | 2.57 M | 29.47 B |
| Net Asset | 2.57 M |
Voyageur Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Voyageur . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 0.85 | |||
| Day Median Price | 0.11 | |||
| Day Typical Price | 0.11 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
About Voyageur Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Voyageur Pharmaceuticals? Buying financial instruments such as Voyageur Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Voyageur Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Voyageur Pink Sheet
Voyageur Pharmaceuticals financial ratios help investors to determine whether Voyageur Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Voyageur with respect to the benefits of owning Voyageur Pharmaceuticals security.